Hormone Receptor Signaling and Breast Cancer Resistance to Anti-Tumor Immunity

Alexandra Moisand1,2, Mathilde Madéry1,2, Thomas Boyer1,2

  • 1CNRS UMR 5164, ImmunoConcEpT, Biological and Medical Sciences Department, University of Bordeaux, 33076 Bordeaux, France.

Insights

Hormone receptor signaling in breast cancer impacts immune response. Modulating hormone pathways may enhance immunotherapy effectiveness for hormone-dependent breast cancers.

Area of Science:

  • Oncology
  • Immunology
  • Endocrinology

Background:

  • Breast cancer comprises diverse subtypes with variable treatment responses.
  • Hormone receptors (estrogen/progesterone) are present in 70-80% of breast cancers, influencing treatment strategies.
  • While immunotherapies show promise, their efficacy in breast cancer, particularly hormone-dependent types, remains limited.

Purpose of the Study:

  • To review the literature on estrogen receptor signaling in breast cancer.
  • To examine how hormone receptor modulation affects anti-tumor immunity and immune evasion.
  • To explore combining hormone therapy with immunotherapy for improved breast cancer treatment.

Main Methods:

  • Literature review of studies on hormone receptor signaling and breast cancer immunity.
  • Analysis of estrogen receptor's role in immune sensitivity and escape mechanisms.
  • Discussion of potential therapeutic strategies combining hormone and immune therapies.

Main Results:

  • Estrogen receptor signaling influences breast cancer cell sensitivity to anti-tumor immune responses.
  • Hormone-dependent breast cancers may exhibit distinct immune evasion strategies.
  • Current immunotherapies are less effective in hormone-dependent breast cancers.

Conclusions:

  • Estrogen receptor signaling is a critical factor in breast cancer's interaction with the immune system.
  • Targeting hormone pathways could potentially enhance the efficacy of cancer immunotherapies.
  • Further research is needed to optimize combination therapies for hormone-dependent breast cancers.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.1K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
8.5K
Chemical Signaling in the Endocrine System01:08

Chemical Signaling in the Endocrine System

A signaling cascade is a series of events that facilitates the transmission of information within or between cells, culminating in a targeted response in the recipient cell. As chemical messengers, hormones are pivotal in initiating and modulating these intricate signaling cascades based on their solubility.
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
3.3K